Particle.news

Download on the App Store

Cipla Reports 30% YoY Profit Growth in Q4 FY25, Announces Rs 16 Dividend

The pharmaceutical giant's revenue rose 9%, with strong regional performance and improved margins, as it marks its 90th anniversary with a special dividend.

Cipla Q4 earnings: Net profit rises 30%, board declares special dividend

Overview

  • Cipla's Q4 FY25 net profit rose 30% year-on-year to Rs 1,222 crore, driven by higher sales in India, North America, and Africa.
  • Revenue from operations increased 9% year-on-year to Rs 6,730 crore, with domestic sales up 8%, North America up 2%, and Africa up 20%.
  • EBITDA grew 16.8% year-on-year to Rs 1,537 crore, with margins improving by 184 basis points to 22.84%.
  • The board recommended a total dividend of Rs 16 per share, including a Rs 3 special dividend to commemorate Cipla's 90th anniversary.
  • Cipla's shares closed 0.49% higher on the BSE at Rs 1,519.45, reflecting positive investor sentiment over the strong results.